Live GMP
Aureate Tradde Ltd GMP ₹0 Hexagon Nutrition Ltd GMP ₹3+6.67% Genxai Analytics Ltd GMP ₹0 Vahh Chemicals Ltd GMP ₹0 CMR Green Technologies Ltd GMP ₹0 Merritronix Ltd GMP ₹93+62.42% Liotech Industries Ltd. GMP ₹0
JFL Life Sciences Ltd. Logo

JFL Life Sciences Ltd. IPO

Closed Fixed Price IPO NSE SME Fresh Capital
← Back to GMP
Issue Price ₹61
GMP
Lot Size 2,000
Face Value ₹10
Issue Size 2,978,000 shares (aggregating up to ₹18 Cr)
Subscription

IPO Timeline

Open Date25-Aug-22
Close Date30-Aug-22
Allotment5-Sep-22
Refund Initiation6-Sep-22
Demat Credit7-Sep-22
UPI Mandate Deadline30-Aug-22
Listing Date8-Sep-22

Category-wise Subscription

Shares offered, bid & amount
CategorySub (x)OfferedBid ForAmt (Cr)*
NII (HNI) 1,414,000 (47%) ₹863 Cr
Retail 1,414,000 (47%) ₹863 Cr
Market Maker 150,000 (5%) ₹9 Cr
Σ  Total2,978,000 (100%)₹18,166 Cr

Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.

Issue Details

Issue Price / Price Band₹61
Face Value₹10
Lot Size2,000 shares
Issue Size2,978,000 shares (aggregating up to ₹18 Cr)
Issue TypeFixed Price IPO
Listing ExchangeNSE SME
Sale TypeFresh Capital
Script Code
Net Offer to Public2,828,000 shares (aggregating up to ₹17 Cr)
Amount InLakhs
Stock Price History · NSE
Loading chart data...
H
L
O
Yahoo Finance · Live

Minimum Investment (Lot-wise)

CategoryLotsSharesAmount (₹)
Retail (Min)12,000₹122,000
Retail (Max)1326,000₹1,586,000
S-HNI (Min)1428,000₹1,708,000
B-HNI (Min)67134,000₹8,174,000
Retail1 lot(s)2,000 shares₹122,000
S-HNI2 lot(s)4,000 shares₹244,000

Shareholding Pattern

Pre-Issue Shareholding8,020,441 shares%
Post-Issue Shareholding10,998,441 shares%
Reserved for Market Maker150,000 shares (aggregating up to ₹1 Cr)

Financial Statements Amount in Lakhs

Metric 31-Aug-19 31-Mar-20 31-Mar-21
Revenue 3,178 3,020 3,287
Profit After Tax 30 36 54
Net Worth 501 538 687
Total Assets 1,615 2,433 2,901
Reserves & Surplus 459 495 638

Valuation & Key Ratios

ROE
ROCE
RONW
PAT Margin
EBITDA Margin
Debt/Equity
P/BV
Pre EPS
Post EPS
Pre P/E27
Post P/E

Grey Market Premium (GMP)

Current GMP

GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.

Objects of the Issue

  • Repayment of secured and unsecured loans. –
  • Funding the working capital requirements of the company. –
  • General Corporate Purposes –

Company Overview

Incorporated in 2010, JFL Life Sciences Limited is engaged in the business of manufacturing of pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets & Capsules (B-Lactam) solid oral dosage form and Tablet and capsules (general) Solid Oral Dosage Form and Oral rehydration solutions (ORS).

The company's sales strategy is to sell the products in bulk to pharmaceutical marketers and traders who in turn provide the channel for sales to customers. JFL Life Sciences Limited has a market presence in PAN India and JFL's products are supplied to 10 developed and developing countries throughout the World.

JFL Life Sciences Limited exports products to African, Middle Eastern, and CIS countries, mainly through merchant exporters. The company is registered with the MOH of Kenya, Nigeria, Yemen, Cambodia & Myanmar for manufacturing a particular product. Few of our products are also registered with Ukraine, Uzbekistan, and Kazakhstan (CIS countries) through merchants.

JFL has two manufacturing units (on lease) in Gujarat.

Competitive Strength :

  1. Product registration
  2. Experienced management and dedicated employee base
  3. Quality assurance
  4. Quality & Brand strength

Company Information

Address309, Satyam Mall, Opp. Saman Complex, Nr. Vishweshwar Mahadev Mandir Settelite Ahmedabad, Gujarat, 380015